Rates of Cardiovascular Events Were Lower in Type 2 Diabetic Patients with Pioglitazone Treatment After Zotarolimus-Eluting Stent Implantation During the Three-Year Follow-Up

被引：0

作者：

Hong, Soon Jun ^{[1
]}

Kim, Je Sang ^{[1
]}

Park, Jae Hyoung ^{[1
]}

Ahn, Chul-Min ^{[1
]}

Lim, Do-Sun ^{[1
]}

机构：

[1] Korea Univ, Dept Cardiol, Anam Hosp, Seoul, South Korea

来源：

CIRCULATION | 2011年 / 124卷 / 21期

关键词：

Ppar; Cardiovascular disease prevention;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A15566

引用

页数：2

共 50 条

[21] THE CLINICAL EVALUATION OF THE ENDEAVOR ZOTAROLIMUS-ELUTING CORONARY STENT IN JAPANESE PATIENTS: FINAL 5-YEAR FOLLOW-UP OF THE ENDEAVOR JAPAN STUDY
Saito, S.
CARDIOLOGY, 2013, 126 : 211 - 211
[22] Serial Angiographic Follow-Up after Successful Implantation of Sirolimus, Paclitaxel, Everolimus and Zotarolimus-Eluting Stent for Chronic Total Occlusions: Multicenter Registry in Asia
Nakamura, Sunao
Ogawa, Hisao
Bae, Jang-Ho
Cahyadi, Yeo H.
Udayachalerm, Wasan
Thesukosol, Damras
Tansuphaswadikul, Sudaratana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B71 - B72
[23] Serial Angiographic Follow-Up after Successful Implantation of Sirolimus, Paclitaxel, Everolimus and Zotarolimus-Eluting Stent for Chronic Total Occlusions: Multicenter Registry in Asia
Nakamura, Sunao
Ogawa, Hisao
Bae, Jang-Ho
Cahyadi, Yeo
Udayachalerm, Wasan
Tresukosol, Damras
Tansuphaswadikul, Sudaratana
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (17) : B130 - B130
[24] The clinical evaluation of the Endeavor zotarolimus-eluting coronary stent in Japanese patients: Final 5-year follow-up of the Endeavor Japan study
Saito, S.
CORONARY ARTERY DISEASE 2013, 2013, : 299 - 301
[25] Serial angiographic follow-up after successful implantation of sirolimus, paclitaxel, everolimus and zotarolimus-eluting stent for chronic total occlusions: multicenter registry in asia
Nakamura, S.
Ogawa, H.
Bae, J. H.
Cahyadi, Y. H.
Udayachalerm, W.
Tresukosol, D.
Tansuphaswadikul, S.
EUROPEAN HEART JOURNAL, 2011, 32 : 747 - 748
[26] Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT Trial
Yokoi, Hiroyoshi
Nakamura, Masato
Muramatsu, Toshiya
Matsuyama, Yutaka
Okada, Hisayuki
Ochiai, Masahiko
Suwa, Satoru
Nanto, Shinsuke
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B71 - B72
[27] Impact of Pioglitazone on Cardiovascular Events in Patients with Diabetes Mellitus after Drug-Eluting Stent Implantation: Evidence from 3-Year Follow-up Results of the J-DESsERT Trial
Yokoi, Hiroyoshi
Nakamura, Masato
Muramatsu, Toshiya
Nanto, Shinsuke
DIABETES, 2014, 63 : A296 - A296
[28] Impact of pioglitazone on cardiovascular events in patients with type-II diabetes mellitus after drug-eluting stent implantation
Yokoi, H.
EUROPEAN HEART JOURNAL, 2016, 37 : 2 - 2
[29] Three-year follow-up after rotational atherectomy for the treatment of diffuse in-stent restenosis: Predictors of major adverse cardiac events
Radke, PW
vom Dahl, J
Hoffmann, R
Klues, HG
Hosseini, M
Janssens, U
Hanrath, P
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2001, 53 (03) : 334 - 340
[30] Usefulness of Liraglutide in Older Patients with Type 2 Diabetes: A Three-Year Follow-Up
Yoshida, Mami
Oh, Eriko
Kimata, Hiroe
Yamamoto, Naomune
Nagata, Kouji
Saeki, Akio
Sugino, Masakazu
Yoshida, Shigeru
Sano, Hiroyuki
Kuzuya, Takeshi
Ohsawa, Nakaaki
Hanafusa, Toshiaki
Imagawa, Akihisa
DIABETES, 2017, 66 : A306 - A306

← 1 2 3 4 5 →